RESUMO
AIM: The aim of this study was to evaluate the efficacy of transcutaneous neuromodulation of the posterior tibial nerve for faecal incontinence and to assess quality of life after the procedure. METHOD: A prospective non-randomized cohort study was conducted in a tertiary centre from September 2010 to May 2013. All patients with faecal incontinence who met the inclusion criteria were included and were treated as outpatients during a 3-month period by unilateral neuromodulation of the posterior tibial nerve. The patients were followed 3-monthly for 1 year. Severity scales, a bowel diary and quality of life scales were evaluated prospectively before and after treatment. RESULTS: Twenty-seven patients of median age 67 (interquartile range 60-69) years and a male to female ratio of 1/6 were included. Faecal incontinence was for solid stools in 48.1% of patients with urgency in 55.6%. About one-third (34.6%) had a sphincter defect on ultrasound and reduction of anal canal pressure in 85.2%. There was a significant improvement in episodes of incontinence on the Wexner score and visual analogue scale assessment and a decrease in the number of episodes of incontinence per unit time. The Fecal Incontinence Quality of Life score was improved at the end of the follow-up. No adverse effects were observed. The cost of the treatment was 135 per patient. CONCLUSION: Transcutaneous posterior tibial nerve neuromodulation provides good treatment for faecal incontinence in terms of efficacy and quality of life.
Assuntos
Incontinência Fecal/terapia , Qualidade de Vida , Nervo Tibial , Estimulação Elétrica Nervosa Transcutânea , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Índice de Gravidade de Doença , Estimulação Elétrica Nervosa Transcutânea/efeitos adversos , Estimulação Elétrica Nervosa Transcutânea/economia , Resultado do TratamentoRESUMO
The objective of this study was to review our experience with using brachioaxillary Diastat vascular grafts (Diastat) compared to standard wall brachioaxillary PTFE grafts (sPTFE) in two similar groups of hemodialysis patients. We conducted a retrospective study comparing complications and graft survival in two similar groups (in terms of age, diabetes mellitus, surgical technique, and previous vascular access) of hemodialysis patients during the period 1994-1997 who had received Diastat (n = 40) or (sPTFE) (n = 40) grafts. We found that the Diastat graft for upper arm hemodialysis access has lower patency and higher complication rates than sPTFE grafts.
